Why you should join Kayentis
At Kayentis, we value each individual and we form a community that goes beyond the
Immunology Case Study
Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study duration can be very long whilst patients are in pain.
To overcome these challenges, Kayentis offers strong and global experience in immuno-inflammation trials, especially with:
Therefore, Kayentis contributes to the success and quality of immunology clinical trials.
Learn more in the case study:
Learn more:
At Kayentis, we value each individual and we form a community that goes beyond the
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
Last update : 31 August 2022